Haegarda Will Join Cinryze for Hereditary Angioedema

October 2017

You'll hear about Haegarda (hay-GAR-duh), a new med to prevent "hereditary angioedema" attacks.

Think of Haegarda as similar to Cinryze. They're both "C1 esterase inhibitors" that are injected twice weekly to keep swelling from this rare genetic disorder at bay.

But be aware of a difference with Haegarda. It's given subcutaneously instead of IV like Cinryze.

Practical advice for a better career, with unlimited access to CE

Hospital Pharmacy Technician's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Hospital Practice Syringe Pullback Isn't Best for Verifying Sterile Compounds
Antifungals Caspofungin Acetate Has Different Storage Than Cancidas
Practice Prepare for a Pharmacy Inspection BEFORE It Happens
Opioids Prevent Opioid Mix-Ups With Patient-Controlled Analgesia (PCA) Orders
New Drugs Haegarda Will Join Cinryze for Hereditary Angioedema
Med Administration Some Central Line Meds Can Be Safely Infused Through Peripheral Lines
Influenza Be Ready to Dispense the 2017-2018 Flu Vaccines
Inhalers Think of ArmonAir as Similar to Flovent
Medication Errors Ensure Safety With Tacrolimus in Your Transplant Patients
Hepatitis C Get Ready for Hep C Meds Mavyret and Vosevi
Bowel Preps Help Ensure Safe and Effective Use of Bowel Preps
Practice Get Our Special Report to Be Ready for the Next Disaster

Haegarda Will Join Cinryze for Hereditary Angioedema

Practical advice for a better career, with unlimited access to CE

Table of Contents